LIPLASOME PHARMA
LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -> LiPlaCis®, Oxaliplatin -> LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects.
LIPLASOME PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Vejle, Syddanmark, Denmark
Country:
Denmark
Website Url:
http://www.liplasome.com
Total Employee:
11+
Status:
Active
Contact:
45 88 70 80 20
Total Funding:
8.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL LiteSpeed
Similar Organizations
Investors List
Incuba Venture
Incuba Venture investment in Series B - LiPlasome Pharma
BankInvest Biomedical Venture
BankInvest Biomedical Venture investment in Series B - LiPlasome Pharma
Vecata
Vecata investment in Series B - LiPlasome Pharma
Official Site Inspections
http://www.liplasome.com
- Host name: linux7.curanet.dk
- IP address: 185.21.40.99
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "LiPlasome Pharma"
LiPlasome Pharma - Crunchbase Company Profile & Funding
LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the …See details»
Vecata A/S - LiPlasome - Bagger-Sorensen
LiPlasome Pharma Plc. is a Danish biotech company focused on cancer therapy. The company has developed a technology based on incapsulation of chemotherapy in liposomes (fatty …See details»
LiPlasome Pharma Company Profile 2024: Valuation, Investors
Information on acquisition, funding, investors, and executives for LiPlasome Pharma. Use the PitchBook Platform to explore the full profile.See details»
LiPlasome Pharma Company Profile - Office Locations ... - Craft
LiPlasome Pharma is a biotech company focused on oncology. It develops targeted lipid technology, which provides a liplasomal reformulation of anticancer drugs.See details»
LiPlasome Pharma - Products, Competitors, Financials, Employees ...
Developer of a prodrug and drug delivery platform. The company develops a prodrug and drug delivery platform designed to be used for the targeted transport of anticancer drugs, such as …See details»
Lipid encapsulated cisplatin - Allarity Therapeutics /LiPlasome …
Jul 5, 2023 · If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password …See details»
CHOSA Oncology AB presents clinical phase 2 results of LiPlaCis …
May 25, 2023 · LiPlaCis is a new formulation of cisplatin, and our tumor gene test, used to predict the individuals who will respond positively to the platinum-based drug, has shown clear …See details»
Oncology Venture enters development deal with Cadila …
In the consortium of owners now including Cadila Pharmaceuticals, LiPlasome, MPI and Oncology Venture – Oncology Venture owns 29% of the total value of the LiPlaCis project after Phase 3. …See details»
Lipid encapsulated oxaliplatin - LiPlasome Pharma - AdisInsight
Jul 28, 2022 · If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with …See details»
Role of LBPA and Alix in Multivesicular Liposome …
Jan 23, 2004 · Here, we found that the unconventional phospholipid lysobisphosphatidic acid (LBPA) could induce the formation of multivesicular liposomes that resembled the multivesicular endosomes that exist where this …See details»
What We Need to Know about Liposomes as Drug …
There are several strategies for liposome preparation using SCF method. In a technique, a compressed mixture of the lipids, SCF and organic co-solvent is injected into the aqueous phase, and sprayed into water to form liposomes …See details»
Liposomes: structure, composition, types, and clinical applications
Dec 31, 2021 · Many liposomal-based drug delivery systems are currently clinically approved to treat several diseases, such as cancer, fungal and viral infections; more liposomes have …See details»
Formation and purification of tailored liposomes for drug delivery ...
Sep 21, 2017 · Liposomes are lipid based bilayer vesicles that can encapsulate, deliver and release low-soluble drugs and small molecules to a specific target site in the body. They are …See details»
Functionalization and higher-order organization of liposomes with …
Aug 29, 2023 · Small unilamellar vesicles (SUVs) are indispensable model membranes, organelle mimics, and drug and vaccine carriers. However, the lack of robust techniques to functionalize …See details»
Basic Methods for Preparation of Liposomes and Studying Their ...
Liposomes are small spherical particles composed mainly from different kind of lipids, which are organised in the form of one or more lipid bilayers. This organisation allows them to be used …See details»
Liposomes: structure, composition, types, and clinical applications ...
May 1, 2022 · Many liposomal-based drug delivery systems are currently clinically approved to treat several diseases, such as cancer, fungal and viral infections; more liposomes have …See details»
Biomimetic Stratum Corneum Liposome Models: Lamellar …
Jan 20, 2023 · In this study, we aim to examine a panel of SC lipid liposome (SCLL) models focusing on using structurally similar CERs and FFAs, rather than the physiologically complex …See details»
Macrophage depletion in inflamed rat knees prevents the …
Nov 20, 2024 · Background Macrophages and mesenchymal stem cells (MSCs) engage in crucial interplay during inflammation and have significant roles in tissue regeneration. Synovial MSCs, …See details»
Liposomes: Structure, Biomedical Applications, and Stability …
Liposomes are lipid bilayer spherical membranes that provide both hydrophilic and hydrophobic environments.See details»